Oncolytics Biotech (ONCY) Announces Publishing of Reovirus and Docetaxel Paper in Patients with Advanced Cancer
Tweet Send to a Friend
Oncolytics Biotech Inc. (Nasdaq: ONCY) announces the publishing of a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
